Abstract
Summary
Background
To report inadvertent intraocular methylprednisolone injection into an eye that had previously undergone superior oblique tuck surgery.
Material and methods
An observational case report.
Results
An inadvertent intraocular penetration occurred following periorbital methylprednisolone injection, which was performed via the superonasal quadrant to relieve trochlear pain in an eye that had undergone previous superior oblique tuck procedure. There was immediate loss of vision, afferent pupillary defect, and raised intraocular pressure. Fundoscopy revealed intravitreal and subretinal methylprednisolone with retinal detachment. Immediate removal of intravitreal and subretinal methylprednisolone was performed with a retinal reattachment procedure. Postoperatively, retinal necrosis was noted in the area that was in contact with methylprednisolone.
Conclusions
This case highlights the risk of inadvertent intraocular penetration while injecting through a limited periorbital space that has been previously operated on.
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Hida T, Chandler D, Arena JE, et al. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol. 1986;101:190–5.
2. Loewenstein A, Zemel E, Lazar M, et al. The effects of Depo-Medrol preservative on the rabbit visual system. Invest Ophthalmol Vis Sci. 1991;32:3053–60.
3. Fahmi A, Bowman R. Administering an eye anaesthetic: principles, techniques, and complications. Community Eye Health. 2008;21(65):14–7.
4. Giles CL. Bulbar perforation during periocular injection of corticosteroids. Am J Ophthalmol. 1974;77:438–41.
5. Gauba V, Kelleher S, Raines MF. A case of inadvertent ocular perforation and intravitreal injection of depomedrone during peribulbar injection. Good visual prognosis with delayed vitrectomy. Eye. 2003;17(9):1039–40.